Literature DB >> 28065772

Multimorbidity in Middle-Aged Adults with Cerebral Palsy.

Nicole Cremer1, Edward A Hurvitz2, Mark D Peterson3.   

Abstract

OBJECTIVE: Individuals with cerebral palsy have less lean body mass, greater relative adiposity, and lower fitness and physical activity participation, and yet the prevalence of age-related multimorbidity in this population has yet to be established. The study objective was to examine the prevalence of lifestyle-related chronic conditions and multimorbidity in a sample of middle-aged adults with cerebral palsy.
METHODS: A clinic-based sample of middle-aged adults with cerebral palsy was examined using Electronic Medical Records Search Engine software. Our cohort included 435 individuals aged 40 to 60 years, with an International Classification of Diseases, Clinical Modification, 9th and 10th Revisions Diagnosis Code for cerebral palsy. Prevalence of 12 chronic conditions was evaluated, including existing diagnoses or historical record of osteopenia/osteoporosis, myocardial infarction, stroke, coronary artery disease, impaired glucose tolerance/type 2 diabetes, other cardiovascular conditions, rheumatoid arthritis, osteoarthritis, asthma, emphysema, prehypertension/hypertension, and hyperlipidemia. Multivariate logistic models were used to estimate multimorbidity (ie, ≥2 chronic conditions), adjusting for age, sex, smoking status, obesity, and Gross Motor Function Classification System (GMFCS).
RESULTS: There were 137 unique multimorbidity combinations. Multimorbidity was significantly more prevalent among obese versus nonobese individuals for both GMFCS I-III (75.8% vs 53.6%) and GMFCS IV-V (79.0% vs 64.2%), but was also significantly higher in nonobese individuals with GMFCS IV-V (64.2%) compared with nonobese individuals with GMFCS I-III (53.6%). Both the obesity status (odds ratio, 2.20; 95% confidence interval, 1.32-2.79) and the GMFCS IV-V category (odds ratio, 1.81; 95% confidence interval, 1.32-3.68) were independently associated with multimorbidity.
CONCLUSIONS: Middle-aged adults with cerebral palsy have high estimates of multimorbidity; both obesity and higher GMFCS levels are independently associated with greater risk.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral palsy; Diabetes; Hypertension; Multimorbidity; Obesity; Osteoporosis

Mesh:

Year:  2017        PMID: 28065772      PMCID: PMC5502778          DOI: 10.1016/j.amjmed.2016.11.044

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  MRT-measurements of muscle volumes of the lower extremities of youths with spastic hemiplegia caused by cerebral palsy.

Authors:  Renée Lampe; Stefan Grassl; Jürgen Mitternacht; Ludger Gerdesmeyer; Reiner Gradinger
Journal:  Brain Dev       Date:  2006-05-11       Impact factor: 1.961

Review 2.  Osteoporosis in adults with cerebral palsy.

Authors:  Kevin J Sheridan
Journal:  Dev Med Child Neurol       Date:  2009-10       Impact factor: 5.449

3.  Chronic Conditions in Adults With Cerebral Palsy.

Authors:  Mark D Peterson; Jennifer M Ryan; Edward A Hurvitz; Elham Mahmoudi
Journal:  JAMA       Date:  2015-12-01       Impact factor: 56.272

4.  Multimorbidity Combinations and Disability in Older Adults.

Authors:  Ana R Quiñones; Sheila Markwardt; Anda Botoseneanu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03-11       Impact factor: 6.053

5.  Obesity misclassification and the metabolic syndrome in adults with functional mobility impairments: Nutrition Examination Survey 2003-2006.

Authors:  Mark D Peterson; Soham Al Snih; Jonathan Stoddard; Anjali Shekar; Edward A Hurvitz
Journal:  Prev Med       Date:  2013-12-18       Impact factor: 4.018

6.  Content validity of the expanded and revised Gross Motor Function Classification System.

Authors:  Robert J Palisano; Peter Rosenbaum; Doreen Bartlett; Michael H Livingston
Journal:  Dev Med Child Neurol       Date:  2008-10       Impact factor: 5.449

7.  Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration.

Authors:  Marshalyn Yeargin-Allsopp; Kim Van Naarden Braun; Nancy S Doernberg; Ruth E Benedict; Russell S Kirby; Maureen S Durkin
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

8.  Fatigue resistance during a voluntary performance task is associated with lower levels of mobility in cerebral palsy.

Authors:  Noelle G Moreau; Li Li; James P Geaghan; Diane L Damiano
Journal:  Arch Phys Med Rehabil       Date:  2008-08-22       Impact factor: 3.966

Review 9.  Muscle deficits in cerebral palsy and early loss of mobility: can we learn something from our elders?

Authors:  Adam Shortland
Journal:  Dev Med Child Neurol       Date:  2009-10       Impact factor: 5.449

10.  Intramuscular fat in ambulant young adults with bilateral spastic cerebral palsy.

Authors:  Jonathan J Noble; Geoffrey D Charles-Edwards; Stephen F Keevil; Andrew P Lewis; Martin Gough; Adam P Shortland
Journal:  BMC Musculoskelet Disord       Date:  2014-07-12       Impact factor: 2.362

View more
  15 in total

1.  Age-related trends in cardiometabolic disease among adults with cerebral palsy.

Authors:  Mark D Peterson; Neil Kamdar; Edward A Hurvitz
Journal:  Dev Med Child Neurol       Date:  2018-04-27       Impact factor: 5.449

2.  Greater Visceral Fat but No Difference in Measures of Total Body Fat in Ambulatory Children With Spastic Cerebral Palsy Compared to Typically Developing Children.

Authors:  Daniel G Whitney; Harshvardhan Singh; Chuan Zhang; Freeman Miller; Christopher M Modlesky
Journal:  J Clin Densitom       Date:  2018-09-22       Impact factor: 2.617

3.  Cardiometabolic disease, depressive symptoms, and sleep disorders in middle-aged adults with functional disabilities: NHANES 2007-2014.

Authors:  Daniel G Whitney; Edward A Hurvitz; Mark D Peterson
Journal:  Disabil Rehabil       Date:  2019-01-17       Impact factor: 3.033

4.  Post-fracture pneumonia risk and association with health and survival outcomes for adults with cerebral palsy: A retrospective cohort study.

Authors:  Daniel G Whitney; Tao Xu; Maryam Berri
Journal:  Bone       Date:  2022-03-17       Impact factor: 4.626

5.  Physical and occupational therapy utilization and associated factors among adults with cerebral palsy: Longitudinal modelling to capture distinct utilization groups.

Authors:  Benjamin C Conner; Tao Xu; Neil S Kamdar; Heidi Haapala; Daniel G Whitney
Journal:  Disabil Health J       Date:  2022-02-15       Impact factor: 4.615

Review 6.  Bone Marrow Fat Physiology in Relation to Skeletal Metabolism and Cardiometabolic Disease Risk in Children With Cerebral Palsy.

Authors:  Daniel G Whitney; Mark D Peterson; Maureen J Devlin; Michelle S Caird; Edward A Hurvitz; Christopher M Modlesky
Journal:  Am J Phys Med Rehabil       Date:  2018-12       Impact factor: 2.159

7.  Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment.

Authors:  Joanna Thomson; Matt Hall; Katherine Nelson; Juan Carlos Flores; Brigid Garrity; Danielle D DeCourcey; Rishi Agrawal; Denise M Goodman; James A Feinstein; Ryan J Coller; Eyal Cohen; Dennis Z Kuo; James W Antoon; Amy J Houtrow; Lucia Bastianelli; Jay G Berry
Journal:  Pediatrics       Date:  2021-01-07       Impact factor: 7.124

8.  Prevalence of high-burden medical conditions and health care resource utilization and costs among adults with cerebral palsy.

Authors:  Daniel G Whitney; Neil S Kamdar; Sophia Ng; Edward A Hurvitz; Mark D Peterson
Journal:  Clin Epidemiol       Date:  2019-06-19       Impact factor: 4.790

9.  Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries.

Authors:  Daniel Whitney; Neil Kamdar; Richard A Hirth; Edward A Hurvitz; Mark D Peterson
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

10.  Noncommunicable disease and multimorbidity in young adults with cerebral palsy.

Authors:  Daniel G Whitney; Edward A Hurvitz; Jennifer M Ryan; Maureen J Devlin; Michelle S Caird; Zachary P French; Elie C Ellenberg; Mark D Peterson
Journal:  Clin Epidemiol       Date:  2018-05-01       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.